Acyclovir Tablets (VA-24-00010023)   3

Background: This solicitation is for the procurement of Acyclovir Tablets by the Department of Veterans Affairs (VA) and the Department of Defense (DoD) through their respective Pharmaceutical Prime Vendor (PPV) Programs. The purpose of this solicitation is to establish a supply source that will provide the drugs listed in the schedule for purchase through the PPV Programs.

The contract will be effective on the date the VA signs the SF-1449 and notifies the offeror (contractor) of award. The Implementation Period will begin when the contract is awarded and end on March 10, 2024. The Ordering Period will begin at the expiration of the Implementation Period and last for one year.

Details: The specific products to be manufactured or delivered under this contract are Acyclovir Tablets. The tablets are available in two strengths: 400mg and 800mg. The tablets are packaged in bottles, with each bottle containing either 100 tablets or 500 tablets, depending on the strength. The schedule of supplies provides detailed information on quantities, package sizes, unit prices, and total amounts for each line item.

Period of Performance: The period of performance for this contract is from the Contract Effective Date to 15 calendar days after the expiration date of the final option period exercised.

Place of Performance: The place of performance for this contract is multiple locations, including all Department of Veterans Affairs (VA) facilities, all Ordering Activities under the Department of Defense (DoD) Pharmaceutical Prime Vendor Program, all Indian Health Service (IHS) facilities, all Bureau of Prisons (BOP) facilities, Captain James A. Lovell Federal Health Care Center (FHCC), and all Option 2 State Veteran Homes.